Maarten Falter, Youri Bekhuis, Wouter L'Hoyes, Mauricio Milani, Sarah Hoedemakers, Lucie Soens, Sara Moura-Ferreira, Sebastiaan Dhont, Rik Pauwels, Annemie Jacobs, Stephanie De Schutter, Boris Delpire, Johan Verbeeck, Jan Stassen, Andreas B Gevaert, Philippe Debonnaire, Alexander Van de Bruaene, Philippe B Bertrand, Lieven Herbots, Ruta Jasaityte, Frederik H Verbrugge, Guido Claessen, Jan Verwerft
{"title":"Exercise Echocardiography for Risk Stratification in Unexplained Dyspnea: the Incremental Value of the mPAP/CO slope.","authors":"Maarten Falter, Youri Bekhuis, Wouter L'Hoyes, Mauricio Milani, Sarah Hoedemakers, Lucie Soens, Sara Moura-Ferreira, Sebastiaan Dhont, Rik Pauwels, Annemie Jacobs, Stephanie De Schutter, Boris Delpire, Johan Verbeeck, Jan Stassen, Andreas B Gevaert, Philippe Debonnaire, Alexander Van de Bruaene, Philippe B Bertrand, Lieven Herbots, Ruta Jasaityte, Frederik H Verbrugge, Guido Claessen, Jan Verwerft","doi":"10.1016/j.echo.2025.06.007","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with unexplained dyspnea and an elevated mean pulmonary artery pressure over cardiac output (mPAP/CO) slope on invasive hemodynamic assessment during exercise have worse clinical outcomes.</p><p><strong>Objectives: </strong>To evaluate the incremental prognostic value of the non-invasive mPAP/CO slope on top of heart failure with preserved ejection fraction (HFpEF) probability scores and diastolic stress testing in patients with unexplained dyspnea.</p><p><strong>Methods: </strong>In a multicenter cohort study involving 6 Belgian dyspnea clinics, patients with unexplained dyspnea underwent exercise echocardiography for mPAP/CO slope assessment. Positive HFpEF scores were defined as HFA-PEFF score ≥5 or H<sub>2</sub>FPEF score ≥6 and negative otherwise. The outcome evaluated was a composite of all-cause mortality or heart failure hospitalization.</p><p><strong>Results: </strong>Among 2452 patients (age 63±15 years, 53% women), a mPAP/CO slope >3.5 mmHg.L<sup>-1</sup>.min best predicted adverse outcomes. The prognostic value of the mPAP/CO slope was greater in patients with negative HFpEF scores than in those with positive scores (interaction p=0.02). The mPAP/CO slope remained independently prognostic after adjustment for NT-proBNP (HR 2.26, 95% CI: 1.33-3.82) and for HFpEF scores and diastolic stress testing (HR 1.99, 95% CI: 1.37-2.88), whereas exercise tricuspid regurgitant velocity did not. Both HFpEF scores-negative patients with a slope >3.5 mmHg.L<sup>-1</sup>.min (HR 2.99 [95%CI 1.81-4.95]) and HFpEF score-positive patients (HR 6.29 [95%CI 4.25-9.31]) showed significantly higher risk compared to HFpEF score-negative patients with a slope ≤3.5 mmHg.L<sup>-1</sup>.min CONCLUSIONS: The mPAP/CO slope-unlike exercise tricuspid regurgitant velocity-adds prognostic value beyond natriuretic peptides, HFpEF scores, and diastolic stress testing, identifying high-risk patients with exercise-induced hemodynamic abnormalities who may benefit from invasive confirmation and closer follow-up.</p>","PeriodicalId":50011,"journal":{"name":"Journal of the American Society of Echocardiography","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Society of Echocardiography","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.echo.2025.06.007","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Patients with unexplained dyspnea and an elevated mean pulmonary artery pressure over cardiac output (mPAP/CO) slope on invasive hemodynamic assessment during exercise have worse clinical outcomes.
Objectives: To evaluate the incremental prognostic value of the non-invasive mPAP/CO slope on top of heart failure with preserved ejection fraction (HFpEF) probability scores and diastolic stress testing in patients with unexplained dyspnea.
Methods: In a multicenter cohort study involving 6 Belgian dyspnea clinics, patients with unexplained dyspnea underwent exercise echocardiography for mPAP/CO slope assessment. Positive HFpEF scores were defined as HFA-PEFF score ≥5 or H2FPEF score ≥6 and negative otherwise. The outcome evaluated was a composite of all-cause mortality or heart failure hospitalization.
Results: Among 2452 patients (age 63±15 years, 53% women), a mPAP/CO slope >3.5 mmHg.L-1.min best predicted adverse outcomes. The prognostic value of the mPAP/CO slope was greater in patients with negative HFpEF scores than in those with positive scores (interaction p=0.02). The mPAP/CO slope remained independently prognostic after adjustment for NT-proBNP (HR 2.26, 95% CI: 1.33-3.82) and for HFpEF scores and diastolic stress testing (HR 1.99, 95% CI: 1.37-2.88), whereas exercise tricuspid regurgitant velocity did not. Both HFpEF scores-negative patients with a slope >3.5 mmHg.L-1.min (HR 2.99 [95%CI 1.81-4.95]) and HFpEF score-positive patients (HR 6.29 [95%CI 4.25-9.31]) showed significantly higher risk compared to HFpEF score-negative patients with a slope ≤3.5 mmHg.L-1.min CONCLUSIONS: The mPAP/CO slope-unlike exercise tricuspid regurgitant velocity-adds prognostic value beyond natriuretic peptides, HFpEF scores, and diastolic stress testing, identifying high-risk patients with exercise-induced hemodynamic abnormalities who may benefit from invasive confirmation and closer follow-up.
期刊介绍:
The Journal of the American Society of Echocardiography(JASE) brings physicians and sonographers peer-reviewed original investigations and state-of-the-art review articles that cover conventional clinical applications of cardiovascular ultrasound, as well as newer techniques with emerging clinical applications. These include three-dimensional echocardiography, strain and strain rate methods for evaluating cardiac mechanics and interventional applications.